Join to View Full Profile
1275 York AvenueNew York, NY 10065
Dr. Xiao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wenbin Xiao is a pathologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from Peking University and has been in practice 14 years. He specializes in hematopathology, anatomic pathology, and clinical pathology and is experienced in leukemia and lymphoma.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematopathology, 2014 - 2016
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2014
Beijing Medical UniversityClass of 2003, MD
Certifications & Licensure
NJ State Medical License 2021 - 2025
NY State Medical License 2016 - 2025
PA State Medical License 2013 - 2016
OH State Medical License 2010 - 2014
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Pathology - Hematology
Publications & Presentations
PubMed
- 1 citationsDefining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.Pallavi Galera, Deepika Dilip, Andriy Derkach, Alexander Chan, Yanming Zhang
Blood. 2025-05-01 - Histiocytoses and reactive proliferations of histiocytes: current state of the art and evolving concepts-a report from the joint CSHP-EA4HP-SH workshop 2024, Hefei, Ch...Falko Fend, Stefan Dirnhofer, Caoimhe Egan, Sophie Song, Zhe Wang
Virchows Archiv. 2025-04-10 - Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy Induction.Meira Yisraeli Salman, Alexander R Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin
Blood Advances. 2025-04-08
Abstracts/Posters
- A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute LeukemiaWenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Stag2 Regulates Hematopoietic Differentiation and Self-Renewal through Alterations in Gene Expression and Topological ControlWenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Mission Bio Launches Single-Cell MRD Assay for Blood Cancer PatientsSeptember 28th, 2023
Grant Support
- Assessing lineage infidelity, oncogenic cooperativity and dependency in RUNX1-mutant acute myeloid leukemiaSLOAN-KETTERING INST CAN RESEARCH2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
